Articles related to CLINICAL STUDY

Unravel the intricacies of the shifting cost and usage trends of first-line treatments for IESS, and join the conversation about the future of managing this condition.

Scientists at the Harvard T.H. Chan School of Public Health are looking at the role of alpha-linolenic acid in ALS management, as their research links high blood levels of this omega-3 fatty acid to slower disease progression and longer survival in patients.

As we grapple with the opioid crisis, this comprehensive study offers crucial insights into the intersection of state medical cannabis laws and chronic noncancer pain treatment, and posits no significant changes in pain treatment due to these laws.

Explore how the persistence of detectable Epstein-Barr virus DNA can serve as a significant predictive marker for nasopharyngeal cancer, potentially revolutionizing early diagnosis and improving survival rates.

The study findings suggest that acalabrutinib and rituximab, a chemo-free therapy option, may offer a new standard of care for older, untreated MCL patients, with promising early complete responses. Yet, more data is needed to understand long-term safety and risk of relapse.

Discover the potential of xanthine dehydrogenase/oxidase blockers, such as allopurinol, in reducing the risk of neurodegenerative diseases. This large-scale study reveals intriguing associations and sets the stage for future research.